Ignite Creation Date:
2025-12-24 @ 12:03 PM
Ignite Modification Date:
2026-01-10 @ 2:52 AM
Study NCT ID:
NCT05649761
Status:
UNKNOWN
Last Update Posted:
2022-12-14
First Post:
2022-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors
Sponsor:
Qilu Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-23
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-24
First Submit QC Date:
None
Study First Post Date:
2022-12-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-05
Last Update Post Date:
2022-12-14
Last Update Post Date Type:
ACTUAL